At the Innovation Cell, we are committed to catalyzing transformative research in health and medicine. As part of the Center for Health Research – DhiShi, our mission is to empower researchers, clinicians, innovators, and institutions through collaborative, end-to-end support that accelerates scientific breakthroughs and improves healthcare outcomes.
From early-stage concepts to published studies, we’ve empowered health research projects with end-to-end innovation support.
Our collaborative network spans multiple countries, bringing together global minds to tackle local and international health challenges.
We’ve directly supported researchers, clinicians, students, and startups with customized strategies, tools, and mentorship.
Our team has helped shape scientific manuscripts and research submissions with high-impact outcomes.
Mechanisms of health and disease across molecular, cellular, and systems levels.
Multi-omics, imaging, real-world data, and AI/ML for hypothesis generation and validation.
From target identification to proof-of-concept.
Linking discovery to diverse populations and equitable outcomes.
Our Discovery Sciences unit delivers comprehensive research services across five integrated stages:






Our discovery work follows a structured yet flexible process designed to maximise scientific novelty, quality, and translational relevance.
Definition of discovery objectives, endpoints, and success criteria
We focus on discovering new biological mechanisms, disease pathways, biomarkers, and data-driven insights that advance understanding of health and disease and enable early translation.
No. Our discovery work spans molecular and cellular biology, omics, computational science, clinical discovery, and population-level research.
Academic researchers, clinicians, health systems, industry partners, startups, and public-sector organisations can collaborate with us.
Yes. We support classical hypothesis-driven research as well as exploratory, AI- and data-driven discovery approaches.
We use standardised protocols, rigorous study design, independent validation, and transparent data and analysis pipelines.
Yes. While Discovery Sciences focuses on early discovery, many projects progress toward biomarkers, diagnostics, targets, or intervention concepts.
All projects follow strict ethical approvals, consent frameworks, data protection standards, and responsible AI principles.
Yes. We integrate population cohorts, clinical data, environmental data, and real-world evidence into discovery workflows.
Validated discoveries can move into translational research, clinical pilots, policy engagement, or commercialisation pathways within DHISHI or with partners.
Timelines vary by scope and complexity, but projects are designed with clear milestones and iterative decision points to accelerate meaningful discovery.